Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 138 entries
Sorted by: Best Match Show Resources per page
Rehabilitation In Resurfacing Hip Arthroplasty Patients: Preliminary Cost-Effectiveness Results From A Clinical Trial.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Fusco F, Campbell H, Newman M, Barker K.
PMID: 27200848
Value Health. 2014 Nov;17(7):A381-2. doi: 10.1016/j.jval.2014.08.2622. Epub 2014 Oct 26.

No abstract available.

Cite
Fusco F, Campbell H, Newman M, et al. Rehabilitation In Resurfacing Hip Arthroplasty Patients: Preliminary Cost-Effectiveness Results From A Clinical Trial. Value Health. 2014;17(7):A381-2doi: 10.1016/j.jval.2014.08.2622.
Fusco, F., Campbell, H., Newman, M., & Barker, K. (2014). Rehabilitation In Resurfacing Hip Arthroplasty Patients: Preliminary Cost-Effectiveness Results From A Clinical Trial. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A381-2. https://doi.org/10.1016/j.jval.2014.08.2622
Fusco, F, et al. "Rehabilitation In Resurfacing Hip Arthroplasty Patients: Preliminary Cost-Effectiveness Results From A Clinical Trial." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A381-2. doi: https://doi.org/10.1016/j.jval.2014.08.2622
Fusco F, Campbell H, Newman M, Barker K. Rehabilitation In Resurfacing Hip Arthroplasty Patients: Preliminary Cost-Effectiveness Results From A Clinical Trial. Value Health. 2014 Nov;17(7):A381-2. doi: 10.1016/j.jval.2014.08.2622. Epub 2014 Oct 26. PMID: 27200848.
Copy Download .nbib Format: NLM
Functionalized nanomaterials for diagnosis and therapy of cancer.

Journal of applied biomaterials & biomechanics : JABB

Pietronave S, Iafisco M, Locarno D, Rimondini L, Maria Prat M.
PMID: 20799167
J Appl Biomater Biomech. 2009 May-Aug;7(2):77-89.

Recent developments in nanotechnology have provided new tools for both cancer imaging and treatment. The functionalization of the nanocarrier based drugs using biological ligands allows increasing specificity of drug targeting enhancing efficacy and reducing side effects. In this paper...

Cite
Pietronave S, Iafisco M, Locarno D, et al. Functionalized nanomaterials for diagnosis and therapy of cancer. J Appl Biomater Biomech. 2009;7(2):77-89
Pietronave, S., Iafisco, M., Locarno, D., Rimondini, L., & Maria Prat, M. (2009). Functionalized nanomaterials for diagnosis and therapy of cancer. Journal of applied biomaterials & biomechanics : JABB, 7(2), 77-89.
Pietronave, Stefano, et al. "Functionalized nanomaterials for diagnosis and therapy of cancer." Journal of applied biomaterials & biomechanics : JABB vol. 7,2 (2009): 77-89.
Pietronave S, Iafisco M, Locarno D, Rimondini L, Maria Prat M. Functionalized nanomaterials for diagnosis and therapy of cancer. J Appl Biomater Biomech. 2009 May-Aug;7(2):77-89. PMID: 20799167.
Copy Download .nbib Format: NLM
Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps.

Translational andrology and urology

Creta M, Longo N, Imbimbo C, Imperatore V, Mirone V, Fusco F.
PMID: 29648553
Transl Androl Urol. 2018 Mar;7:S111-S113. doi: 10.21037/tau.2017.12.02.

No abstract available.

Cite
Creta M, Longo N, Imbimbo C, et al. Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps. Transl Androl Urol. 2018;7:S111-S113doi: 10.21037/tau.2017.12.02.
Creta, M., Longo, N., Imbimbo, C., Imperatore, V., Mirone, V., & Fusco, F. (2018). Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps. Translational andrology and urology, 7S111-S113. https://doi.org/10.21037/tau.2017.12.02
Creta, Massimiliano, et al. "Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps." Translational andrology and urology vol. 7 (2018): S111-S113. doi: https://doi.org/10.21037/tau.2017.12.02
Creta M, Longo N, Imbimbo C, Imperatore V, Mirone V, Fusco F. Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps. Transl Androl Urol. 2018 Mar;7:S111-S113. doi: 10.21037/tau.2017.12.02. PMID: 29648553; PMCID: PMC5881212.
Copy Download .nbib Format: NLM
The societal burden of chronic liver diseases: results from the COME study.

BMJ open gastroenterology

Scalone L, Fagiuoli S, Ciampichini R, Gardini I, Bruno R, Pasulo L, Lucà MG, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani LG.
PMID: 26462277
BMJ Open Gastroenterol. 2015 Mar 30;2(1):e000025. doi: 10.1136/bmjgast-2014-000025. eCollection 2015.

OBJECTIVE: Chronic liver diseases (CLDs) impose a significant socioeconomic burden on patients and the healthcare system, but to what extent remains underexplored. We estimated costs and health-related-quality-of-life (HRQoL) among patients with CLDs at different stages and with different aetiologies.DESIGN:...

Cite
Scalone L, Fagiuoli S, Ciampichini R, et al. The societal burden of chronic liver diseases: results from the COME study. BMJ Open Gastroenterol. 2015;2(1):e000025doi: 10.1136/bmjgast-2014-000025.
Scalone, L., Fagiuoli, S., Ciampichini, R., Gardini, I., Bruno, R., Pasulo, L., Lucà, M. G., Fusco, F., Gaeta, L., Del Prete, A., Cesana, G., & Mantovani, L. G. (2015). The societal burden of chronic liver diseases: results from the COME study. BMJ open gastroenterology, 2(1), e000025. https://doi.org/10.1136/bmjgast-2014-000025
Scalone, Luciana, et al. "The societal burden of chronic liver diseases: results from the COME study." BMJ open gastroenterology vol. 2,1 (2015): e000025. doi: https://doi.org/10.1136/bmjgast-2014-000025
Scalone L, Fagiuoli S, Ciampichini R, Gardini I, Bruno R, Pasulo L, Lucà MG, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani LG. The societal burden of chronic liver diseases: results from the COME study. BMJ Open Gastroenterol. 2015 Mar 30;2(1):e000025. doi: 10.1136/bmjgast-2014-000025. eCollection 2015. PMID: 26462277; PMCID: PMC4599156.
Copy Download .nbib Format: NLM
Giant isolated intracardiac thrombus presenting as acute heart failure secondary to right ventricular outflow tract obstruction in a patient with renal carcinoma.

Oxford medical case reports

Ballo P, Fibbi V, Granelli M, Fusco F, Abbondanti A, Fantini A, Bartalini M, Consalvo M, Fazi A, Santoro GM.
PMID: 29977577
Oxf Med Case Reports. 2018 Jun 11;2018(6):omy019. doi: 10.1093/omcr/omy019. eCollection 2018 Jun.

Right-sided intracardiac thrombi are potential causes of right ventricular (RV) failure, particularly when tricuspid or pulmonary obstruction occurs. In most cases, RV thrombus develops in patients with RV dysfunction and concomitant thrombosis in the systemic veins. However, RV thrombosis...

Cite
Ballo P, Fibbi V, Granelli M, et al. Giant isolated intracardiac thrombus presenting as acute heart failure secondary to right ventricular outflow tract obstruction in a patient with renal carcinoma. Oxf Med Case Reports. 2018;2018(6):omy019doi: 10.1093/omcr/omy019.
Ballo, P., Fibbi, V., Granelli, M., Fusco, F., Abbondanti, A., Fantini, A., Bartalini, M., Consalvo, M., Fazi, A., & Santoro, G. M. (2018). Giant isolated intracardiac thrombus presenting as acute heart failure secondary to right ventricular outflow tract obstruction in a patient with renal carcinoma. Oxford medical case reports, 2018(6), omy019. https://doi.org/10.1093/omcr/omy019
Ballo, Piercarlo, et al. "Giant isolated intracardiac thrombus presenting as acute heart failure secondary to right ventricular outflow tract obstruction in a patient with renal carcinoma." Oxford medical case reports vol. 2018,6 (2018): omy019. doi: https://doi.org/10.1093/omcr/omy019
Ballo P, Fibbi V, Granelli M, Fusco F, Abbondanti A, Fantini A, Bartalini M, Consalvo M, Fazi A, Santoro GM. Giant isolated intracardiac thrombus presenting as acute heart failure secondary to right ventricular outflow tract obstruction in a patient with renal carcinoma. Oxf Med Case Reports. 2018 Jun 11;2018(6):omy019. doi: 10.1093/omcr/omy019. eCollection 2018 Jun. PMID: 29977577; PMCID: PMC6007396.
Copy Download .nbib Format: NLM
Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients.

Cancers

Mercadante S, Marchetti P, Cuomo A, Caraceni A, Mediati RD, Vellucci R, Mammucari M, Natoli S, Lazzari M, Dauri M, Adile C, Airoldi M, Azzarello G, Bandera M, Blasi L, Cartenì G, Chiurazzi B, Costanzo BVP, Degiovanni D, Fusco F, Guardamagna V, Iaffaioli V, Liguori S, Palermo L, Mameli S, Masedu F, Mattioli R, Mazzei T, Melotti RM, Menardo V, Miotti D, Moroso S, Pascoletti G, De Santis S, Orsetti R, Papa A, Ricci S, Scelzi E, Sofia M, Tonini G, Valle A, Aielli F.
PMID: 29865170
Cancers (Basel). 2018 Jun 01;10(6). doi: 10.3390/cancers10060175.

No abstract available.

Cite
Mercadante S, Marchetti P, Cuomo A, et al. Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. Cancers (Basel). 2018;10(6)doi: 10.3390/cancers10060175.
Mercadante, S., Marchetti, P., Cuomo, A., Caraceni, A., Mediati, R. D., Vellucci, R., Mammucari, M., Natoli, S., Lazzari, M., Dauri, M., Adile, C., Airoldi, M., Azzarello, G., Bandera, M., Blasi, L., Cartenì, G., Chiurazzi, B., Costanzo, B. V. P., Degiovanni, D., Fusco, F., Guardamagna, V., Iaffaioli, V., Liguori, S., Palermo, L., Mameli, S., Masedu, F., Mattioli, R., Mazzei, T., Melotti, R. M., Menardo, V., Miotti, D., Moroso, S., Pascoletti, G., De Santis, S., Orsetti, R., Papa, A., Ricci, S., Scelzi, E., Sofia, M., Tonini, G., Valle, A., Aielli, F. (2018). Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. Cancers, 10(6), . https://doi.org/10.3390/cancers10060175
Mercadante, Sebastiano, et al. "Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients." Cancers vol. 10,6 (2018). doi: https://doi.org/10.3390/cancers10060175
Mercadante S, Marchetti P, Cuomo A, Caraceni A, Mediati RD, Vellucci R, Mammucari M, Natoli S, Lazzari M, Dauri M, Adile C, Airoldi M, Azzarello G, Bandera M, Blasi L, Cartenì G, Chiurazzi B, Costanzo BVP, Degiovanni D, Fusco F, Guardamagna V, Iaffaioli V, Liguori S, Palermo L, Mameli S, Masedu F, Mattioli R, Mazzei T, Melotti RM, Menardo V, Miotti D, Moroso S, Pascoletti G, De Santis S, Orsetti R, Papa A, Ricci S, Scelzi E, Sofia M, Tonini G, Valle A, Aielli F. Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. Cancers (Basel). 2018 Jun 01;10(6). doi: 10.3390/cancers10060175. PMID: 29865170; PMCID: PMC6025469.
Copy Download .nbib Format: NLM
Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?.

Acta diabetologica

Delvecchio M, Salzano G, Bonura C, Cauvin V, Cherubini V, d'Annunzio G, Franzese A, Giglio S, Grasso V, Graziani V, Iafusco D, Iughetti L, Lera R, Maffeis C, Maltoni G, Mantovani V, Menzaghi C, Patera PI, Rabbone I, Reindstadler P, Scelfo S, Tinto N, Toni S, Tumini S, Lombardo F, Nicolucci A, Barbetti F.
PMID: 29948406
Acta Diabetol. 2018 Sep;55(9):981-983. doi: 10.1007/s00592-018-1179-y. Epub 2018 Jun 13.

No abstract available.

Cite
Delvecchio M, Salzano G, Bonura C, et al. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta Diabetol. 2018;55(9):981-983doi: 10.1007/s00592-018-1179-y.
Delvecchio, M., Salzano, G., Bonura, C., Cauvin, V., Cherubini, V., d'Annunzio, G., Franzese, A., Giglio, S., Grasso, V., Graziani, V., Iafusco, D., Iughetti, L., Lera, R., Maffeis, C., Maltoni, G., Mantovani, V., Menzaghi, C., Patera, P. I., Rabbone, I., Reindstadler, P., Scelfo, S., Tinto, N., Toni, S., Tumini, S., Lombardo, F., Nicolucci, A., Barbetti, F. (2018). Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta diabetologica, 55(9), 981-983. https://doi.org/10.1007/s00592-018-1179-y
Delvecchio, Maurizio, et al. "Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?." Acta diabetologica vol. 55,9 (2018): 981-983. doi: https://doi.org/10.1007/s00592-018-1179-y
Delvecchio M, Salzano G, Bonura C, Cauvin V, Cherubini V, d'Annunzio G, Franzese A, Giglio S, Grasso V, Graziani V, Iafusco D, Iughetti L, Lera R, Maffeis C, Maltoni G, Mantovani V, Menzaghi C, Patera PI, Rabbone I, Reindstadler P, Scelfo S, Tinto N, Toni S, Tumini S, Lombardo F, Nicolucci A, Barbetti F. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. Acta Diabetol. 2018 Sep;55(9):981-983. doi: 10.1007/s00592-018-1179-y. Epub 2018 Jun 13. PMID: 29948406.
Copy Download .nbib Format: NLM
Synergistic Release of Crop Nutrients and Stimulants from Hydroxyapatite Nanoparticles Functionalized with Humic Substances: Toward a Multifunctional Nanofertilizer.

ACS omega

Yoon HY, Lee JG, Esposti LD, Iafisco M, Kim PJ, Shin SG, Jeon JR, Adamiano A.
PMID: 32258895
ACS Omega. 2020 Mar 16;5(12):6598-6610. doi: 10.1021/acsomega.9b04354. eCollection 2020 Mar 31.

The use of salt- or macro-sized NPK fertilizers is typically associated with low nutrient use efficiency and water eutrophication. Nanotechnology can overcome such drawbacks, but its practical application on a large scale is limited by (i) high costs and...

Cite
Yoon HY, Lee JG, Esposti LD, et al. Synergistic Release of Crop Nutrients and Stimulants from Hydroxyapatite Nanoparticles Functionalized with Humic Substances: Toward a Multifunctional Nanofertilizer. ACS Omega. 2020;5(12):6598-6610doi: 10.1021/acsomega.9b04354.
Yoon, H. Y., Lee, J. G., Esposti, L. D., Iafisco, M., Kim, P. J., Shin, S. G., Jeon, J. R., & Adamiano, A. (2020). Synergistic Release of Crop Nutrients and Stimulants from Hydroxyapatite Nanoparticles Functionalized with Humic Substances: Toward a Multifunctional Nanofertilizer. ACS omega, 5(12), 6598-6610. https://doi.org/10.1021/acsomega.9b04354
Yoon, Ho Young, et al. "Synergistic Release of Crop Nutrients and Stimulants from Hydroxyapatite Nanoparticles Functionalized with Humic Substances: Toward a Multifunctional Nanofertilizer." ACS omega vol. 5,12 (2020): 6598-6610. doi: https://doi.org/10.1021/acsomega.9b04354
Yoon HY, Lee JG, Esposti LD, Iafisco M, Kim PJ, Shin SG, Jeon JR, Adamiano A. Synergistic Release of Crop Nutrients and Stimulants from Hydroxyapatite Nanoparticles Functionalized with Humic Substances: Toward a Multifunctional Nanofertilizer. ACS Omega. 2020 Mar 16;5(12):6598-6610. doi: 10.1021/acsomega.9b04354. eCollection 2020 Mar 31. PMID: 32258895; PMCID: PMC7114695.
Copy Download .nbib Format: NLM
Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials.

European urology focus

Creta M, Cornu JN, Roehrborn CG, Finazzi Agrò E, Montorsi F, Longo N, Imperatore V, De Sio M, Arcaniolo D, Mirone V, Fusco F.
PMID: 32057739
Eur Urol Focus. 2021 Mar;7(2):440-443. doi: 10.1016/j.euf.2020.01.014. Epub 2020 Feb 10.

We performed a post hoc analysis of data from phase 3 and 4 studies to evaluate the efficacy of silodosin 8mg in patients with severe lower urinary tract symptoms (LUTS) related to benign prostatic obstruction (BPO). The presence of...

Cite
Creta M, Cornu JN, Roehrborn CG, et al. Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials. Eur Urol Focus. 2020;7(2):440-443doi: 10.1016/j.euf.2020.01.014.
Creta, M., Cornu, J. N., Roehrborn, C. G., Finazzi Agrò, E., Montorsi, F., Longo, N., Imperatore, V., De Sio, M., Arcaniolo, D., Mirone, V., & Fusco, F. (2021). Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials. European urology focus, 7(2), 440-443. https://doi.org/10.1016/j.euf.2020.01.014
Creta, Massimiliano, et al. "Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials." European urology focus vol. 7,2 (2021): 440-443. doi: https://doi.org/10.1016/j.euf.2020.01.014
Creta M, Cornu JN, Roehrborn CG, Finazzi Agrò E, Montorsi F, Longo N, Imperatore V, De Sio M, Arcaniolo D, Mirone V, Fusco F. Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials. Eur Urol Focus. 2021 Mar;7(2):440-443. doi: 10.1016/j.euf.2020.01.014. Epub 2020 Feb 10. PMID: 32057739.
Copy Download .nbib Format: NLM
Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.

Scientific reports

Tosi GM, Neri G, Caldi E, Fusco F, Bacci T, Tarantello A, Nuti E, Marigliani D, Baiocchi S, Traversi C, Barbarino M, Eandi CM, Parolini B, Mundo L, Santucci A, Orlandini M, Galvagni F.
PMID: 29955097
Sci Rep. 2018 Jun 29;8(1):10141. doi: 10.1038/s41598-018-28203-5.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Cite
Tosi GM, Neri G, Caldi E, et al. Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration. Sci Rep. 2018;8(1):10141doi: 10.1038/s41598-018-28203-5.
Tosi, G. M., Neri, G., Caldi, E., Fusco, F., Bacci, T., Tarantello, A., Nuti, E., Marigliani, D., Baiocchi, S., Traversi, C., Barbarino, M., Eandi, C. M., Parolini, B., Mundo, L., Santucci, A., Orlandini, M., & Galvagni, F. (2018). Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration. Scientific reports, 8(1), 10141. https://doi.org/10.1038/s41598-018-28203-5
Tosi, Gian Marco, et al. "Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration." Scientific reports vol. 8,1 (2018): 10141. doi: https://doi.org/10.1038/s41598-018-28203-5
Tosi GM, Neri G, Caldi E, Fusco F, Bacci T, Tarantello A, Nuti E, Marigliani D, Baiocchi S, Traversi C, Barbarino M, Eandi CM, Parolini B, Mundo L, Santucci A, Orlandini M, Galvagni F. Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration. Sci Rep. 2018 Jun 29;8(1):10141. doi: 10.1038/s41598-018-28203-5. PMID: 29955097; PMCID: PMC6023889.
Copy Download .nbib Format: NLM
Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars.

American journal of ophthalmology

Yu AC, Spena R, Fusco F, Dondi R, Myerscough J, Fabbri F, Bovone C, Busin M.
PMID: 34627739
Am J Ophthalmol. 2021 Oct 07;236:20-31. doi: 10.1016/j.ajo.2021.09.036. Epub 2021 Oct 07.

PURPOSE: To report the outcomes of 2-piece microkeratome-assisted mushroom keratoplasty (MK) for eyes with full-thickness traumatic corneal scars and otherwise functional endothelium following corneal penetrating injury.DESIGN: This was an interventional case series.METHODS: In this single-center study, 41 consecutive eyes...

Cite
Yu AC, Spena R, Fusco F, et al. Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. Am J Ophthalmol. 2021;236:20-31doi: 10.1016/j.ajo.2021.09.036.
Yu, A. C., Spena, R., Fusco, F., Dondi, R., Myerscough, J., Fabbri, F., Bovone, C., & Busin, M. (2021). Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. American journal of ophthalmology, 23620-31. https://doi.org/10.1016/j.ajo.2021.09.036
Yu, Angeli Christy, et al. "Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars." American journal of ophthalmology vol. 236 (2021): 20-31. doi: https://doi.org/10.1016/j.ajo.2021.09.036
Yu AC, Spena R, Fusco F, Dondi R, Myerscough J, Fabbri F, Bovone C, Busin M. Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. Am J Ophthalmol. 2021 Oct 07;236:20-31. doi: 10.1016/j.ajo.2021.09.036. Epub 2021 Oct 07. PMID: 34627739.
Copy Download .nbib Format: NLM
Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars.

American journal of ophthalmology

Yu AC, Spena R, Fusco F, Dondi R, Myerscough J, Fabbri F, Bovone C, Busin M.
PMID: 34627739
Am J Ophthalmol. 2021 Oct 07;236:20-31. doi: 10.1016/j.ajo.2021.09.036. Epub 2021 Oct 07.

PURPOSE: To report the outcomes of 2-piece microkeratome-assisted mushroom keratoplasty (MK) for eyes with full-thickness traumatic corneal scars and otherwise functional endothelium following corneal penetrating injury.DESIGN: This was an interventional case series.METHODS: In this single-center study, 41 consecutive eyes...

Cite
Yu AC, Spena R, Fusco F, et al. Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. Am J Ophthalmol. 2021;236:20-31doi: 10.1016/j.ajo.2021.09.036.
Yu, A. C., Spena, R., Fusco, F., Dondi, R., Myerscough, J., Fabbri, F., Bovone, C., & Busin, M. (2021). Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. American journal of ophthalmology, 23620-31. https://doi.org/10.1016/j.ajo.2021.09.036
Yu, Angeli Christy, et al. "Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars." American journal of ophthalmology vol. 236 (2021): 20-31. doi: https://doi.org/10.1016/j.ajo.2021.09.036
Yu AC, Spena R, Fusco F, Dondi R, Myerscough J, Fabbri F, Bovone C, Busin M. Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. Am J Ophthalmol. 2021 Oct 07;236:20-31. doi: 10.1016/j.ajo.2021.09.036. Epub 2021 Oct 07. PMID: 34627739.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 138 entries